Do mental disorders and eating patterns affect long-term weight loss maintenance? - 11/08/11
, Martina de Zwaan, M.D. b, Barbara Mühlhans, Psy.D. b, Frank Petrak, Ph.D. a, Stephan Herpertz, M.D. aAbstract |
Objective |
This study aimed to assess the impact of mental disorders on weight loss maintenance among initially successful weight losers who participated in a very-low-calorie diet program.
Method |
A total of 251 obese individuals were assessed in a prospective longitudinal study over a period of 4 years. Mental disorders and eating patterns were assessed by structured interviews at baseline and by standardized questionnaires at baseline (T1), after 1 year (T2) and on 3-year follow-up (T3). Analyses were performed with an intention-to-treat method.
Results |
Based on the intention-to-treat sample, 166 successful weight losers at T2 (weight loss ≥10%) were identified. Of those, 47 (28.3%) maintained a weight loss of ≥5% of their pretreatment weight, whereas 119 (71.7%) maintained a loss of less than 5% of their pretreatment weight at T3. History of substance abuse/dependence disorder and grazing prior to treatment increased the likelihood of successful weight loss maintenance. High levels of cognitive control, low levels of disinhibition on 3-year follow-up and initial body mass index also were associated with successful weight loss maintenance.
Conclusion |
Strategies that helped individuals overcome earlier mental disorders might help to establish better self-regulation and maintain high cognitive control of eating and subsequently increase the possibility of maintaining weight loss in the long run.
Le texte complet de cet article est disponible en PDF.Keywords : Predictor variables on weight loss, Depression, Binge eating, VLCD weight loss treatment, Successful weight loss, Weight loss maintenance
Plan
| ☆ | S. Herpertz has received honoraria or travel support from Lilly, Lundbeck, Pfizer and Sanofi-Aventis. F. Petrak has received honoraria and grant/research support from Pfizer, Berlin-Chemie, Lilly and Novo Nordisk Pharma. |
| ☆☆ | T.M. Legenbauer, M. de Zwaan and B. Mühlhans report no conflict of interest. |
Vol 32 - N° 2
P. 132-140 - mars 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
